AN2 Therapeutics, Inc.'s total assets for Q2 2025 were $75.83M, a decrease of -6.78% from the previous quarter. ANTX total liabilities were $6.98M for the fiscal quarter, a -12.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.